McKesson's 3.16% Drop Amid $1.13B Volume Surge Ranks 84th in Market Activity
McKesson (MCK) closed on September 25 with a 3.16% decline, despite a 62.57% surge in trading volume to $1.13 billion, ranking it 84th in market activity. The stock's performance reflects shifting dynamics in the healthcare distribution sector amid broader market volatility.
Recent developments suggest renewed scrutiny of McKesson's supply chain operations. Regulatory investigations into its opioid distribution practices remain a key overhang, with pending lawsuits potentially impacting long-term profitability. Analysts highlight that while the company has diversified into value-added services like clinical analytics, its core wholesale segment remains vulnerable to pricing pressures and regulatory headwinds.
Market participants are closely monitoring McKesson's inventory management strategies. Recent reports indicate the company has adjusted regional distribution center operations to optimize logistics costs. These operational tweaks, though incremental, could influence short-term investor sentiment if they demonstrate improved efficiency without compromising service levels.
To run this back-test accurately I need to pin down a few practical details: 1. Stock universe • Do you want all U.S. exchange-listed equities (NYSE + NASDAQ) or a different market? • Are ETFs and ADRs included or excluded? 2. Weighting scheme • Equal-weight each of the 500 names every day (the usual approach), or something else? 3. Data availability Building a fresh list of the 500 highest-volume names for every trading day since 2022 requires full-universe daily volume data. • I can pull that if we stick to U.S. common stocks only; it will just take a few minutes to retrieve and process. • If you prefer a quicker approximation (e.g., limit to the S&P 500 constituents or the Russell 1000 universe) let me know. Once these points are settled I can generate the data retrieval plan, run the strategy back-test, and deliver the performance report with visualizations. How would you like to proceed?


Comentarios
Aún no hay comentarios